Lista de obras - Anita Mangia - Dominio Público Uruguay

3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer

artículo científico publicado en 2005

Association of pS2 (TFF1) release with breast tumour proliferative rate: in vitro and in vivo studies.

artículo científico publicado en 1999

Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer.

artículo científico publicado en 2011

BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy

article

Bcl6/p53 expression, macrophages/mast cells infiltration and microvascular density in invasive breast carcinoma.

artículo científico publicado en 2018

Benefit from anthracyclines in relation to biological profiles in early breast cancer.

artículo científico publicado en 2014

Biological role of NHERF1 protein expression in breast cancer.

artículo científico publicado en 2009

Biomarkers for Early Cancer Detection - Methodological Aspects.

artículo científico publicado en 2010

CES2, ABCG2, TS and Topo-I primary and synchronous metastasis expression and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI regimen

artículo científico publicado en 2014

Characterization of a serum protein pattern from NSCLC patients treated with Gefitinib

artículo científico publicado en 2011

Chromogenic in situ hybridization to detect EGFR gene copy number in cell blocks from fine-needle aspirates of non small cell lung carcinomas and lung metastases from colo-rectal cancer

artículo científico publicado en 2010

Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer

scientific article published on 07 January 2014

Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of beta-tubulins

artículo científico

Cytosol cathepsin-D content and proliferative activity of human breast cancer. The Comitato Italiano per il Controllo di Qualita del Laboratorio in Oncologia

artículo científico publicado en 1992

Cytosolic levels of estrogen-regulated pS2 protein in breast cancer: correlation with tumor proliferative activity

scientific article published on 01 January 1993

Expression of proteins involved in DNA damage response in familial and sporadic breast cancer patients.

artículo científico publicado en 2015

FISH testing of HER2 immunohistochemistry 1+ invasive breast cancer with unfavorable characteristics. ⬇️

artículo científico publicado en 2016

Failure of primary breast cancer neoangiogenesis to predict pattern of distant metastasis.

artículo científico publicado en 2001

Fine Needle Aspiration Cytology: A Tool to Study NHERF1 Expression as a Potential Marker of Aggressiveness in Lung Cancer.

artículo científico publicado en 2015

Frizzled-10 and cancer progression: Is it a new prognostic marker?

artículo científico publicado en 2017

Gene copy number variation in male breast cancer by aCGH.

artículo científico publicado en 2011

Gene copy number variation in male breast cancer by aCGH.

artículo científico publicado en 2010

Genetic heterogeneity by comparative genomic hybridization in BRCAx breast cancers

artículo científico publicado en 2008

HER-2 expression and cell proliferation: prognostic markers in patients with node-negative breast cancer.

artículo científico publicado en 2003

Heterogeneity of intratumour proliferative activity in primary breast cancer: biological and clinical aspects

artículo científico publicado en 1995

Hierarchical clustering analysis identifies metastatic colorectal cancers patients with more aggressive phenotype

artículo científico publicado en 2017

High density of tryptase-positive mast cells in human colorectal cancer: a poor prognostic factor related to protease-activated receptor 2 expression

artículo científico publicado en 2013

Hormone receptor modulation by a sequential alternate TAM/MPA administration monitored by drugs plasma level

artículo científico publicado en 1990

Human epidermal growth factor receptor 2, Na+/H+ exchanger regulatory factor 1, and breast cancer susceptibility gene-1 as new biomarkers for familial breast cancers.

artículo científico publicado en 2011

Immune Prophets of Lung Cancer: The Prognostic and Predictive Landscape of Cellular and Molecular Immune Markers

article published in 2018

Immunoprofile from tissue microarrays to stratify familial breast cancer patients

artículo científico publicado en 2015

Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy.

artículo científico publicado en 2016

Involvement of nuclear NHERF1 in colorectal cancer progression.

artículo científico publicado en 2012

Irradiation-induced angiosarcoma and anti-angiogenic therapy: a therapeutic hope?

artículo científico publicado en 2013

Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients? ⬇️

artículo científico publicado en 2016

Liver X Receptors Inhibit Proliferation of Human Colorectal Cancer Cells and Growth of Intestinal Tumors in Mice ⬇️

artículo científico publicado el 16 de febrero de 2013

Mammographic aspect, cell kinetics and hormone receptor status of operable breast cancer

scientific article published on 01 March 1993

NHERF1 Between Promises and Hopes: Overview on Cancer and Prospective Openings

artículo científico publicado en 2018

NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma.

artículo científico publicado en 2018

NHERF1 together with PARP1 and BRCA1 expression as a new potential biomarker to stratify breast cancer patients.

artículo científico publicado en 2017

NHERF1/EBP50 in Breast Cancer: Clinical Perspectives

artículo científico publicado en 2010

Na+/H+ exchanger regulatory factor 1 expression levels in blood and tissue predict breast tumour clinical behaviour

artículo científico publicado en 2011

Nuclear NHERF1 expression as a prognostic marker in breast cancer.

artículo científico publicado en 2013

Nuclear PARP1 expression and its prognostic significance in breast cancer patients.

artículo científico publicado en 2015

Overexpression of nuclear NHERF1 in advanced colorectal cancer: association with hypoxic microenvironment and tumor invasive phenotype

scientific article published on 13 March 2012

Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosis.

artículo científico publicado en 2012

Phosphatidylinositol 3-kinase in breast cancer: where from here?

artículo científico publicado en 2007

Prognostic Relevance of Mitotic Activity in Patients with Node-Negative Breast Cancer

scientific article published on 01 November 2003

Prognostic relevance of histological grade and its components in node-negative breast cancer patients.

artículo científico publicado en 2004

Randomised clinical trial of adjuvant chemotherapy in patients with node-negative, fast-proliferating breast cancer

scientific article published on 01 January 1993

Randomized clinical trial of adjuvant fluorouracil, epirubicin, and cyclophosphamide chemotherapy for patients with fast-proliferating, node-negative breast cancer.

artículo científico publicado en 2001

Role of miR-27a, miR-181a and miR-20b in gastric cancer hypoxia-induced chemoresistance

artículo científico publicado en 2016

SELDI-TOF serum proteomics and breast cancer: which perspective?

artículo científico publicado en 2008

Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients?

artículo científico publicado en 2019

Sister chromatid exchange: A possible approach to characterize familial breast cancer patients

artículo científico publicado en 2014

Sorafenib (BAY 43-9006) in hepatocellular carcinoma patients: from discovery to clinical development.

artículo científico

The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysis

artículo científico publicado en 2009

The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells.

artículo científico publicado en 2007

The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy

artículo científico publicado en 2015

The prognostic value of the Na⁺/ H⁺ exchanger regulatory factor 1 (NHERF1) protein in cancer.

artículo científico

Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer

artículo científico publicado en 2015

Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC.

artículo científico publicado en 2009

Tissue remodelling in breast cancer: human mast cell tryptase as an initiator of myofibroblast differentiation

artículo científico publicado en 2011

VEGF and TWIST1 in a 16-biomarker immunoprofile useful for prognosis of breast cancer patients.

artículo científico publicado en 2017

VEGF, HIF-1α expression and MVD as an angiogenic network in familial breast cancer

artículo científico publicado en 2013

β-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients

artículo científico publicado en 2016

Lista de obras de Anita Mangia

3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer

Association of pS2 (TFF1) release with breast tumour proliferative rate: in vitro and in vivo studies.

Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer.

BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy

Bcl6/p53 expression, macrophages/mast cells infiltration and microvascular density in invasive breast carcinoma.

Benefit from anthracyclines in relation to biological profiles in early breast cancer.

Biological role of NHERF1 protein expression in breast cancer.

Biomarkers for Early Cancer Detection - Methodological Aspects.

CES2, ABCG2, TS and Topo-I primary and synchronous metastasis expression and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI regimen

Characterization of a serum protein pattern from NSCLC patients treated with Gefitinib

Chromogenic in situ hybridization to detect EGFR gene copy number in cell blocks from fine-needle aspirates of non small cell lung carcinomas and lung metastases from colo-rectal cancer

Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer

Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of beta-tubulins

Cytosol cathepsin-D content and proliferative activity of human breast cancer. The Comitato Italiano per il Controllo di Qualita del Laboratorio in Oncologia

Cytosolic levels of estrogen-regulated pS2 protein in breast cancer: correlation with tumor proliferative activity

Expression of proteins involved in DNA damage response in familial and sporadic breast cancer patients.

FISH testing of HER2 immunohistochemistry 1+ invasive breast cancer with unfavorable characteristics. ⬇️

Failure of primary breast cancer neoangiogenesis to predict pattern of distant metastasis.

Fine Needle Aspiration Cytology: A Tool to Study NHERF1 Expression as a Potential Marker of Aggressiveness in Lung Cancer.

Frizzled-10 and cancer progression: Is it a new prognostic marker?

Gene copy number variation in male breast cancer by aCGH.

Gene copy number variation in male breast cancer by aCGH.

Genetic heterogeneity by comparative genomic hybridization in BRCAx breast cancers

HER-2 expression and cell proliferation: prognostic markers in patients with node-negative breast cancer.

Heterogeneity of intratumour proliferative activity in primary breast cancer: biological and clinical aspects

Hierarchical clustering analysis identifies metastatic colorectal cancers patients with more aggressive phenotype

High density of tryptase-positive mast cells in human colorectal cancer: a poor prognostic factor related to protease-activated receptor 2 expression

Hormone receptor modulation by a sequential alternate TAM/MPA administration monitored by drugs plasma level

Human epidermal growth factor receptor 2, Na+/H+ exchanger regulatory factor 1, and breast cancer susceptibility gene-1 as new biomarkers for familial breast cancers.

Immune Prophets of Lung Cancer: The Prognostic and Predictive Landscape of Cellular and Molecular Immune Markers

Immunoprofile from tissue microarrays to stratify familial breast cancer patients

Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy.

Involvement of nuclear NHERF1 in colorectal cancer progression.

Irradiation-induced angiosarcoma and anti-angiogenic therapy: a therapeutic hope?

Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients? ⬇️

Liver X Receptors Inhibit Proliferation of Human Colorectal Cancer Cells and Growth of Intestinal Tumors in Mice ⬇️

Mammographic aspect, cell kinetics and hormone receptor status of operable breast cancer

NHERF1 Between Promises and Hopes: Overview on Cancer and Prospective Openings

NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma.

NHERF1 together with PARP1 and BRCA1 expression as a new potential biomarker to stratify breast cancer patients.

NHERF1/EBP50 in Breast Cancer: Clinical Perspectives

Na+/H+ exchanger regulatory factor 1 expression levels in blood and tissue predict breast tumour clinical behaviour

Nuclear NHERF1 expression as a prognostic marker in breast cancer.

Nuclear PARP1 expression and its prognostic significance in breast cancer patients.

Overexpression of nuclear NHERF1 in advanced colorectal cancer: association with hypoxic microenvironment and tumor invasive phenotype

Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosis.

Phosphatidylinositol 3-kinase in breast cancer: where from here?

Prognostic Relevance of Mitotic Activity in Patients with Node-Negative Breast Cancer

Prognostic relevance of histological grade and its components in node-negative breast cancer patients.

Randomised clinical trial of adjuvant chemotherapy in patients with node-negative, fast-proliferating breast cancer

Randomized clinical trial of adjuvant fluorouracil, epirubicin, and cyclophosphamide chemotherapy for patients with fast-proliferating, node-negative breast cancer.

Role of miR-27a, miR-181a and miR-20b in gastric cancer hypoxia-induced chemoresistance

SELDI-TOF serum proteomics and breast cancer: which perspective?

Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients?

Sister chromatid exchange: A possible approach to characterize familial breast cancer patients

Sorafenib (BAY 43-9006) in hepatocellular carcinoma patients: from discovery to clinical development.

The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysis

The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells.

The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy

The prognostic value of the Na⁺/ H⁺ exchanger regulatory factor 1 (NHERF1) protein in cancer.

Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer

Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC.

Tissue remodelling in breast cancer: human mast cell tryptase as an initiator of myofibroblast differentiation

VEGF and TWIST1 in a 16-biomarker immunoprofile useful for prognosis of breast cancer patients.

VEGF, HIF-1α expression and MVD as an angiogenic network in familial breast cancer

β-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients